RE: Tests....12 Nov 2020 15:02
Market
The Directors of Braveheart have been conducting a continuous review of the fast changing situation regarding possible COVID-19 vaccines and also other companies that are developing COVID-19 tests. The very positive interim trial results of a vaccine developed by Pfizer and BioNTech are hugely encouraging and welcomed by everyone. However, the Directors believe that the roll out of a vaccine will not lessen the urgent need for a fast, specific and sensitive test for COVID-19 which is what Paraytec is focusing on bringing to market as soon as possible. The Directors' expectation is that any vaccine that becomes available to protect against COVID-19 will be, initially at least, used for the protection of front line health workers and the very vulnerable. The Directors therefore believe that the best way to protect the rest of the population will be to allow mass testing. This is what Paraytec's test is focused on achieving.